JUPITER, Fla.--(BUSINESS WIRE)--Dyadic International, Inc. (AMEX:DIL), a global biotechnology company that uses its patented and proprietary technologies (the “Dyadic Platform Technology”) to conduct research and development activities for the discovery, development and manufacture of products and enabling solutions to the bioenergy, industrial enzyme and pharmaceutical industries, today announced financial results for the year ended December 31, 2006.
